Abstract
Valvular calcification is a common finding in patients with end-stage chronic kidney disease (CKD) and associated with increased all-cause and cardiovascular mortality. The aim of the study was to determine the prevalence and risk factors associated with cardiac valve calcification in patients with stage IV and V CKD, not yet on dialysis. The study enrolled 61 CKD patients (34 M, mean age 62.6±13.6 years) and 22 ageand sex-matched healthy controls. All participants underwent a clinical assessment, laboratory analyses, echocardiography and carotid artery ultrasound. Calcification of the aortic and mitral valve was more frequently in patients with CKD stages IV-V than the healthy controls (47.5% : 9.1%, p=0.001). CKD patients were divided according to the presence of valvular calcification in 2 groups: group A with calcification (n=29) and group B without calcification (n=32). Patients from group A were significantly older (p<0.01), had lower creatinine clearance (p<0.01), and higher levels of P (p <0.05), CaxP product (p<0.05) and PTH (p<0.05) compared to patients from group B. Echocardiography showed a higher prevalence of left ventricular hypertrophy (LVH, p<0.01) in group A compared with group B. In patients of group A, carotid intima-media thickness (IMT) was higher (p<0.001) and calcified plaques were more frequent (p=0.005) than those in group B. Valvular calcification is highly prevalent in the predialysis period of CKD and is associated with disorders of mineral metabolism, left ventricular hypertrophy and vascular calcification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have